The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Given Imaging's revenues will expand 8.3% and EPS will grow 25.0%.
The average estimate for revenue is $48.2 million. On the bottom line, the average EPS estimate is $0.20.
Last quarter, Given Imaging notched revenue of $40.6 million. GAAP reported sales were 2.9% lower than the prior-year quarter's $41.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $0.05. GAAP EPS were -$0.01 for Q1 against $0.01 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 77.1%, 150 basis points better than the prior-year quarter. Operating margin was 0.2%, 80 basis points worse than the prior-year quarter. Net margin was -0.5%, 100 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $193.7 million. The average EPS estimate is $0.69.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 123 members out of 138 rating the stock outperform, and 15 members rating it underperform. Among 26 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 23 give Given Imaging a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Given Imaging is outperform, with an average price target of $20.33.
Is Given Imaging the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Given Imaging to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.